{"news_desk": "Letters", "print_page": null, "section_name": "Opinion", "subsection_name": null, "byline": [], "abstract": null, "type_of_material": "Letter", "word_count": "255", "lead_paragraph": "The Healthcare Supply Chain Association says the backlog of new generic drug applications at the F.D.A. is compounding the problem of price increases.", "pub_date": "2016-05-19T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "The Generic Drug Market", "content_kicker": "Letter", "kicker": "Letter"}, "snippet": "The Healthcare Supply Chain Association says the backlog of new generic drug applications at the F.D.A. is compounding the problem of price increases.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/05/19/opinion/the-generic-drug-market.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Generic Brands and Products", "name": "subject"}], "blog": [], "_id": "573c916038f0d86c87c2cefb", "source": "The New York Times"}